BeiGene (BGNE) Tops Q2 EPS by 309c

BeiGene (NASDAQ: BGNE) reported Q2 EPS of ($0.28), $3.09 better than the analyst estimate of ($3.37). Revenue for the quarter came in at $554 million versus the consensus estimate of $499.59 million.

For earnings history and earnings-related data on BeiGene (BGNE) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c